MEDIvsETF 2ETF Comparison
VS
Choose a second ETF to run a side-by-side ETF comparison with MEDI, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
MEDI performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 07/24/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | MEDI ETF 2 | +3.86%– | +11.77%– | +5.41%– | +20.88%– | +50.97%– | n/a– |
| Flows | MEDI ETF 2 | -– | +$11M– | +$14M– | +$20M– | +$31M– | -– |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | MEDI ETF 2 | +22.21%– | +20.11%– | +19.30%– | n/a– |
| Max drawdown | MEDI ETF 2 | -6.05%– | -15.29%– | -19.41%– | n/a– |
| Max drawdown duration | MEDI ETF 2 | 17d– | 212d– | 350d– | n/a– |
Trading data
MEDI | ETF 2 | |
Last sale 7/24/2026 at 1:30 PM | $33.10 | – |
| Previous close 07/24/2026 | $33.07 | – |
| Consolidated volume 07/24/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Advertisement
Main metrics
Last update 7/24/2026 at 1:30 PM
Live
Closed
MEDI | ETF 2 | |
|---|---|---|
| Last price | $33.10 | – |
| 1D performance | +0.09% | – |
| AuM | $42.24 M | – |
| E/R | 0.8% | – |
Characteristics
MEDI | ETF 2 | |
|---|---|---|
| Management strategy | Active | – |
| Provider | Harbor Capital | – |
| Benchmark | - | – |
| N° of holdings | 38 | – |
| Asset class | - | – |
| Trailing 12m distribution yield | Join | Join |
| Inception date | November 16, 2022 | – |
| ESG | No | – |
Advertisement
Exposure
Countries
MEDI
USA
77.37%
Other
22.63%
ETF 2
Sectors
MEDI
Healthcare
83.8%
Other
16.2%
ETF 2
Advertisement
Diversification
MEDI
Total weight of top 15 holdings out of 15
74.21%
ETF 2
–
Top 15 holdings
Data as of June 30, 2026
MEDI
Eli Lilly & Co.
21.09%
US04351P1012
14.15%
Gilead Sciences, Inc.
4.52%
Legend Biotech Corp.
4.37%
Rhythm Pharmaceuticals, Inc.
4.29%
AbbVie, Inc.
3.27%
Intuitive Surgical, Inc.
3.13%
Insmed, Inc.
2.84%
Revolution Medicines, Inc.
2.67%
Natera, Inc.
2.66%
Boston Scientific Corp.
2.65%
Merck & Co., Inc.
2.35%
Danaher Corp.
2.15%
Vaxcyte, Inc.
2.08%
Abivax SA
2.00%
ETF 2
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
–
Advertisement
Advertisement
